3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile
C23H27FN8 — CID 146645717
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile
3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile (PubChem CID 146645717) has the molecular formula C23H27FN8 and a molecular weight of 434.52 g/mol. Its IUPAC name is 3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile.
Molecular Properties
| Compound Name | 3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile |
|---|---|
| PubChem CID | 146645717 |
| Molecular Formula | C23H27FN8 |
| Molecular Weight | 434.52 g/mol |
| Exact Mass | 434.23 |
| IUPAC Name | 3-[7-[[7-fluoro-4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-9-azabicyclo[3.3.1]nonan-3-yl]propanenitrile |
| SMILES | Cc1cc(Nc2nc(NC3CC4CC(CCC#N)CC(C3)N4)nc3cc(F)ccc23)n[nH]1 |
| InChI | InChI=1S/C23H27FN8/c1-13-7-21(32-31-13)29-22-19-5-4-15(24)10-20(19)28-23(30-22)27-18-11-16-8-14(3-2-6-25)9-17(12-18)26-16/h4-5,7,10,14,16-18,26H,2-3,8-9,11-12H2,1H3,(H3,27,28,29,30,31,32) |
| InChIKey | BXJCLSMPVZMWIC-UHFFFAOYSA-N |
| XLogP | 4.16 |
| TPSA | 114.34 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.52 |
| LogP ≤ 5 | 4.16 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146645717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.